2-({1-[(tert-butoxy)carbonyl]azetidin-3-yl}oxy)-1,3-thiazole-5-carboxylic acid
Structure Info
- Chemspace ID
- CSSB02127161970 (In-Stock Building Blocks)
- IUPAC Name
- 2-({1-[(tert-butoxy)carbonyl]azetidin-3-yl}oxy)-1,3-thiazole-5-carboxylic acid
- Mol formula
- C12H16N2O5S
- Mol weight
- 300 Da
- Catalog Number(s)
- BBLS02127161970, BBV-239668762, EN300-52456653, bbls02127161970
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.76
- Heavy atoms count
- 20
- Rotatable bond count
- 5
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.583
- Polar surface area (Å)
- 89
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSB02127161970
Items Overall 14 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 186.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 277.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 396.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 624.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 800.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 1,568.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 5 g | 2,318.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 10 g | 3,438.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 186.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 277.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 396.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 624.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 800.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 2.5 g | 1,568.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 2-({1-[(tert-butoxy)carbonyl]piperidin-4-yl}oxy)-1,3-thiazole-5-carboxylic acid - CSSB02133227593](/st/structure/200/783d6f55d642dea3c46e7b26600bc262/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CCC%2528CC1%2529OC1%253DNC%253DC%2528S1%2529C%2528O%2529%253DO.png)
![Chemical structure of 2-{1-[(tert-butoxy)carbonyl]azetidin-3-yl}-1,3-thiazole-5-carboxylic acid - CSSB00037860587](/st/structure/200/ffdc88ac14e155a1c9ca33d6e0be1c2e/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CC%2528C1%2529C1%253DNC%253DC%2528S1%2529C%2528O%2529%253DO.png)
![Chemical structure of tert-butyl 3-[(5-formyl-1,3-thiazol-2-yl)oxy]azetidine-1-carboxylate - CSSB20469762697](/st/structure/200/c9c91235497b490b36c915e383764788/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CC%2528C1%2529OC1%253DNC%253DC%2528S1%2529C%253DO.png)
![Chemical structure of tert-butyl 3-[(5-bromo-1,3-thiazol-2-yl)oxy]azetidine-1-carboxylate - CSSB03550047987](/st/structure/200/3da03c60a2de61266ade59d6df5f0997/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CC%2528C1%2529Oc2ncc%2528Br%2529s2.png)
![Chemical structure of 3-({1-[(tert-butoxy)carbonyl]azetidin-3-yl}oxy)-1H-pyrazole-4-carboxylic acid - CSSB02517316495](/st/structure/200/2e8f4fe5c3f276baca849053ec5b45b9/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CC%2528C1%2529OC1%253DNNC%253DC1C%2528O%2529%253DO.png)
![Chemical structure of 2-{4-[(tert-butoxy)carbonyl]piperazin-1-yl}-1,3-thiazole-5-carboxylic acid - CSSB00011548420](/st/structure/200/86550b73ca629543e775459e288acbee/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CCN%2528CC1%2529C1%253DNC%253DC%2528S1%2529C%2528O%2529%253DO.png)
![Chemical structure of 2-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-1,3-thiazole-5-carboxylic acid - CSSB00030131647](/st/structure/200/7a3c074bc7a28ef6f8600f27b7459fda/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CCC%2528CC1%2529C1%253DNC%253DC%2528S1%2529C%2528O%2529%253DO.png)
